PT  - JOURNAL ARTICLE
AU  - Allieta, Mattia
AU  - Sebastiano, Davide Rossi
TI  - Hospitalization as reliable indicator of second wave COVID-19 pandemic in eight European countries
AID  - 10.1101/2020.12.31.20249084
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.12.31.20249084
4099  - http://medrxiv.org/content/early/2021/01/05/2020.12.31.20249084.short
4100  - http://medrxiv.org/content/early/2021/01/05/2020.12.31.20249084.full
AB  - Time dependent reproduction number (Rt) is one of the most popular parameters to track the impact of COVID-19 pandemic. However, especially at the initial stages, Rt can be highly underestimated because of remarkable differences between the actual number of infected people and the daily incidence of people who are tested positive. Here, we present the analysis of daily cumulative number of hospitalized (HP) and intensive care unit (ICU) patients both in space and in time in the early phases of second wave COVID-19 pandemic across eight different European countries, namely Austria, Belgium, Czech Republic, France, Italy, Portugal, Spain, and United Kingdom. We derive simple model equations to fit the time dependence of these two variables where exponential behavior is observed. Growth rate constants of HP and ICU are listed, providing country-specific parameters able to estimate the burden of SARS-COV-2 infection before extensive containment measures take place. Our quantitative parameters, fully related to hospitalizations, are disentangled from the capacity range of the screening campaign, for example the number of swabs, and they cannot be directly biased by the actual number of infected people. This approach can give an array of reliable indicators which can be used by governments and healthcare systems to monitor the dynamics of COVID-19 epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work does not need any approval of the IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings were derived from the following resources available in the public domain: https://www.ages.at https://www.sciensano.be https://www.mzcr.cz https://www.gouvernement.fr https://www.salute.gov.it https://www.sns.gov.pt https://www.mscbs.gob.es https://www.gov.uk https://ec.europa.eu/eurostat https://www.ages.at https://www.sciensano.be https://www.mzcr.cz https://www.gouvernement.fr https://www.salute.gov.it https://www.sns.gov.pt https://www.mscbs.gob.es https://www.gov.uk https://ec.europa.eu/eurostat